about
Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatusCryopreserved vitamin D3-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients.Myelin peptides in multiple sclerosis.Similar biological effect of high-dose oral versus intravenous methylprednisolone in multiple sclerosis relapses.A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.Defining secondary progressive multiple sclerosis.Myelitis: Differences between multiple sclerosis and other aetiologies.Progressive multifocal leukoencephalopathy associated to natalizumab extended dosing regimen.Baseline Differences in Minor Lymphocyte Subpopulations may Predict Response to Fingolimod in Relapsing-Remitting Multiple Sclerosis Patients.Analysis of the pain in multiple sclerosis patients.Adherence to disease-modifying therapies in spanish patients with relapsing multiple sclerosis: two-year interim results of the global adherence project.Evaluation of the anti-HIV activity of natalizumab, an antibody against integrin alpha4.The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis.Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates.Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS.Monitoring CD49d receptor occupancy: A method to optimize and personalize natalizumab therapy in multiple sclerosis patients.Multiparametric flow cytometric analysis of whole blood reveals changes in minor lymphocyte subpopulations of multiple sclerosis patients.Beneficial effect of tolerogenic dendritic cells pulsed with MOG autoantigen in experimental autoimmune encephalomyelitis.Utility of oligoclonal IgG band detection for MS diagnosis in daily clinical practice.Baseline clinical status as a predictor of methylprednisolone response in multiple sclerosis relapsesStable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patientsSpecific T-cell proliferation to myelin peptides in relapsing-remitting multiple sclerosisHepatitis tóxica tras tratamiento concomitante con interferón beta y aloe vera en un paciente con esclerosis múltiple: a propósito de un casoTh1Th17CM Lymphocyte Subpopulation as a Predictive Biomarker of Disease Activity in Multiple Sclerosis Patients under Dimethyl Fumarate or Fingolimod Treatment
P50
Q36827205-56907839-05E1-40D6-9D87-7D9E94FE1826Q36919825-143D4352-C5A7-4569-B547-D682886AEDCCQ37459184-636BEF9E-7870-47B5-9BE8-D267D155F1FDQ38425076-4439D3BC-9C5D-433E-91A6-A979800A2735Q38442625-A5FBA7F7-FEBE-40CF-AC33-3392E72CF826Q38843046-A3D42962-743C-4809-B4C0-84557DD82BE9Q40993238-57344587-07FA-43C7-84CD-10103BCE1755Q41168849-5CD45968-AA89-4913-A1AD-286DD1635B2AQ42491880-586531C9-D443-4694-BAA5-307C69A20B16Q44166600-82284EB3-F4D1-4860-99EF-EAB96042CD55Q45182486-859FF426-B707-4E47-A860-7EC0F4C62E0BQ46180976-F6C23AF6-1116-4948-A8A5-90944896CE8DQ46704299-3BD50DC6-527A-408D-9E17-C1197DFC604FQ47618323-EA10B63B-D80A-41DC-B3D7-04A53FCC7A46Q47639943-46BB64D9-4032-4C67-9F58-CC330AB3E160Q48607199-CB01D57D-2BC5-4ABD-AA07-195E194C4DE7Q48669278-6527DD1D-323C-4690-A881-7BDAE68FFB31Q50673650-1FEAD451-DAAA-4657-9A01-903FFB792033Q51034724-7F945BAA-86A9-4A90-9800-38C69D0C0970Q53085945-1EBB71BB-C12E-4136-995C-0265EB87F460Q57601791-C090D681-83B0-4B40-97DB-157239B3C711Q61656600-CA70C194-4907-47A2-BF36-DE1F755B5654Q61656610-8B803B13-8064-425B-B874-80FAA4845C7EQ62534979-FA694B6E-337A-46BA-9270-4071B3E04E8DQ92186974-199A1905-E1AA-487B-9C94-4128A34DAF52
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cristina Ramo-Tello
@ast
Cristina Ramo-Tello
@en
Cristina Ramo-Tello
@es
Cristina Ramo-Tello
@nl
Cristina Ramo-Tello
@sl
type
label
Cristina Ramo-Tello
@ast
Cristina Ramo-Tello
@en
Cristina Ramo-Tello
@es
Cristina Ramo-Tello
@nl
Cristina Ramo-Tello
@sl
prefLabel
Cristina Ramo-Tello
@ast
Cristina Ramo-Tello
@en
Cristina Ramo-Tello
@es
Cristina Ramo-Tello
@nl
Cristina Ramo-Tello
@sl
P106
P21
P31
P496
0000-0001-8643-5053